Literature DB >> 10497864

Human anti-Pseudomonas aeruginosa outer membrane proteins IgG cross-protective against infection with heterologous immunotype strains of P. aeruginosa.

N G Lee1, B Y Ahn, S B Jung, Y G Kim, Y Lee, H S Kim, W J Park.   

Abstract

In order to develop an effective means to treat and prevent Pseudomonas aeruginosa infections, we have purified P. aeruginosa outer membrane protein (Oprs)-specific human IgG antibody using a large-scale affinity column. In this study, we investigated the cross-protective activity of the purified anti-Oprs IgG against various immunotype strains of P. aeruginosa. The anti-Oprs IgG reacted with Oprs isolated from seven Fisher-Devlin immunotype strains of P. aeruginosa and was able to promote opsonophagocytic killing of all seven immunotype strains by human phagocytic cells. Administration of 500 microg anti-Oprs IgG to mice raised the LD50 of the P. aeruginosa strains by 8-250-fold, indicating the protective capacity against heterologous P. aeruginosa strains as well as homologous strains. In contrast, despite high titers against P. (aeruginosa Oprs, total serum IgG isolated from burn patient sera was no better than normal serum IgG in protecting mice from infection with P. aeruginosa. These data demonstrate that the affinity-purified human anti-Oprs IgG could afford protection against heterologous immunotype P. aeruginosa strains and provide a rationale to use anti-Oprs IgG as an adjunct for treatment of P. aeruginosa infections in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497864     DOI: 10.1111/j.1574-695X.1999.tb01358.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  3 in total

1.  Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa.

Authors:  B M Price; D R Galloway; N R Baker; L B Gilleland; J Staczek; H E Gilleland
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Opr86 is essential for viability and is a potential candidate for a protective antigen against biofilm formation by Pseudomonas aeruginosa.

Authors:  Yosuke Tashiro; Nobuhiko Nomura; Ryoma Nakao; Hidenobu Senpuku; Reiko Kariyama; Hiromi Kumon; Saori Kosono; Haruo Watanabe; Toshiaki Nakajima; Hiroo Uchiyama
Journal:  J Bacteriol       Date:  2008-04-04       Impact factor: 3.490

3.  Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.

Authors:  Lucia Peluso; Cristiana de Luca; Silvia Bozza; Antonio Leonardi; Gloria Giovannini; Alfonso Lavorgna; Gaetano De Rosa; Massimo Mascolo; Loredana Ortega De Luna; Maria Rosaria Catania; Luigina Romani; Fabio Rossano
Journal:  BMC Microbiol       Date:  2010-01-13       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.